The role of an expanded family of exported effector kinases in environmental sensing and regulation of virulence in human malaria.
This project aims to investigate the role of FIKK kinases in regulating cytoadhesion and rigidity of Plasmodium falciparum-infected red blood cells to understand malaria pathogenesis.
Projectdetails
Introduction
The most severe form of malaria in humans is caused by Plasmodium falciparum. Cytoadhesion of infected red blood cells (iRBCs) to host endothelium and iRBC rigidification are the major contributors to pathology.
Cytoadhesion Mechanism
Cytoadhesion is mediated by the transport of a protein called PfEMP1 onto the surface of the iRBC. It prevents clearance of iRBCs in the spleen and promotes parasite survival, but can cause the obstruction of blood vessels leading to pathology.
Balance of Survival and Pathology
Thus, the parasite has to strike a fine balance between preventing its own clearance through sufficiently strong cytoadhesion and control of rigidity, and killing the host. The paradigm in the field is that the strength of cytoadhesion is dominated by the expression of PfEMP1 variants with different affinities for host cell receptors.
Regulation of Cytoadhesive Properties
We now have strong evidence that the parasite can rapidly regulate its cytoadhesive properties using a family of atypical kinases (the FIKK kinases) it exports into the host cell. This gives the parasite a yet unrecognized ability to respond to conditions encountered in the host, such as fever or hypoxia in areas of high parasite sequestration, and influence disease outcome.
Importance of FIKK Kinases
This is important: Of the 6 human infecting Plasmodium species, only P. falciparum exports FIKK kinases into the host cell. As this species is responsible for ~95% of all fatal human malaria cases, it is paramount to understand FIKK function in pathogenesis.
Research Objectives
We will use cutting-edge approaches to:
- Identify the function of FIKK kinases in controlling cytoadhesion and rigidity in conditions frequently encountered in the human host and determine RBC remodelling in samples from patients.
- Identify the molecular underpinnings of FIKK function in controlling cytoadhesion.
- Perform a thorough biochemical characterization of the atypical FIKK kinase family.
Conclusion
In summary, we aim to answer the paramount question about the functional role and the evolution of the FIKK kinases and the pathogenesis of P. falciparum malaria.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.999.935 |
Totale projectbegroting | € 1.999.935 |
Tijdlijn
Startdatum | 1-9-2023 |
Einddatum | 31-8-2028 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- FUNDACAO CALOUSTE GULBENKIANpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Molecular mimicry and immune evasion in malaria parasitesThe Trojan project aims to investigate how malaria parasites use rifin proteins to manipulate host immunity, enhancing their persistence and revealing new insights for combating malaria. | ERC Advanced... | € 2.499.923 | 2024 | Details |
The unusual role of a highly divergent Arp2/3 complex in the mosquito stages of malaria parasites.This project aims to elucidate the role of a Plasmodium-specific Arp2/3 complex in mosquito development to identify new antimalarial strategies targeting malaria transmission. | ERC Starting... | € 1.499.527 | 2025 | Details |
Cell cycle progression in malaria parasitesThe JANUS project aims to unravel the unique cell cycle mechanisms of Plasmodium falciparum through transcriptomics and proteomics, enhancing understanding of malaria pathogenesis and potential treatments. | ERC Starting... | € 1.499.928 | 2024 | Details |
The malaria chemical atlas: Revealing the parasite-host functional interactomeThe MalChemAtlas project aims to uncover the chemical communication of the malaria parasite Plasmodium falciparum to develop novel interventions against malaria. | ERC Consolid... | € 2.000.000 | 2023 | Details |
How has the rapid scale up of malaria control in Africa impacted vector competence?This project aims to investigate the effects of insecticide use and drug resistance on malaria parasite development in mosquitoes to enhance vector control strategies and improve intervention options. | ERC Starting... | € 1.499.581 | 2023 | Details |
Molecular mimicry and immune evasion in malaria parasites
The Trojan project aims to investigate how malaria parasites use rifin proteins to manipulate host immunity, enhancing their persistence and revealing new insights for combating malaria.
The unusual role of a highly divergent Arp2/3 complex in the mosquito stages of malaria parasites.
This project aims to elucidate the role of a Plasmodium-specific Arp2/3 complex in mosquito development to identify new antimalarial strategies targeting malaria transmission.
Cell cycle progression in malaria parasites
The JANUS project aims to unravel the unique cell cycle mechanisms of Plasmodium falciparum through transcriptomics and proteomics, enhancing understanding of malaria pathogenesis and potential treatments.
The malaria chemical atlas: Revealing the parasite-host functional interactome
The MalChemAtlas project aims to uncover the chemical communication of the malaria parasite Plasmodium falciparum to develop novel interventions against malaria.
How has the rapid scale up of malaria control in Africa impacted vector competence?
This project aims to investigate the effects of insecticide use and drug resistance on malaria parasite development in mosquitoes to enhance vector control strategies and improve intervention options.